 | Up a level |
Chu, D., Lessard, D., Laymouna, M. A., Engler, K., Schuster, T., Ma, Y., Kronfli, N., Routy, J.-P., Hijal, T., Lacombe, K., Sheehan, N., Rougier, H., & Lebouché, B. (2022). Understanding the Risks and Benefits of a Patient Portal Configured for HIV Care: Patient and Healthcare Professional Perspectives. Journal of Personalized Medicine, 12(2), 14 pages. External link
Engler, K., Vicente, S., Ma, Y., Hijal, T., Cox, J., Ahmed, S., Klein, M., Achiche, S., Pant Pai, N., de Pokomandy, A., Lacombe, K., & Lebouché, B. (2021). Implementation of an electronic patient-reported measure of barriers to antiretroviral therapy adherence with the Opal patient portal: Protocol for a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic. PLOS ONE, 16(12), 19 pages. External link
Laymouna, M., Ma, Y., Lessard, D., Engler, K., Therrien, R., Schuster, T., Vicente, S., Achiche, S., Haj, M. N. E., Lemire, B., Kawaiah, A., & Lebouché, B. (2024). Needs-assessment for an artificial intelligence-based Chatbot for pharmacists in HIV care: results from a knowledge–attitudes–practices survey. Healthcare, 12(16), 1661-1661. Available
Laymouna, M., Ma, Y., Lessard, D., Schuster, T., Engler, K., & Lebouché, B. (2024). Roles, users, benefits and limitations of chatbots in health care : rapid review. Journal of Medical Internet Research, 26. External link
Lessard, D., Engler, K., Ma, Y., Rodriguez Cruz, A., Vicente, S., Kronfli, N., Barkati, S., Brouillette, M.-J., Cox, J., Kildea, J., Hijal, T., Pomey, M.-P., Bartlett, S. J., Asselah, J., & Lebouché, B. (2022). Remote follow-up of self-isolating COVID-19 patients with a patient portal: Protocol for a mixed-method pilot study (the Opal-COVID study). JMIR Res Protoc, 18(11). External link
Ma, Y., Achiche, S., Pomey, M.-P., Paquette, J., Adjtoutah, N., Vicente, S., Engler, K., Laymouna, M., Lessard, D., Lemire, B., Asselah, J., Therrien, R., Osmanlliu, E., Zawati, M. H., Joly, Y., & Lebouché, B. (2024). Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study). JMIR Research Protocols, 13, 54668. External link
Ma, Y., Vincente, S., Engler, K., Achiche, S., Thériault, L., Lemire, B., Tu, G., Frih, I., Nait El Haj, M., Laymouna, M. A., de Polomandy, A., Cox, J., & Lebouché, B. (2022, October). An artificial intelligence-based Chatbot aimed at promoting HIV self-management : quantitative results of a mixed-method usability study [Poster]. Fast-Track Cities 2022, Seville, Spain. Unavailable
Ma, Y., Engler, K., Vincente, S., Achiche, S., Lemire, B., Rodrigez Cruz, A., Thériault, L., Soussou, S., Régazzoni, B., Tu, G., Nait Ei Haj, M., de Polomandy, A., Cox, J., Zahedi Niaki, N., & Lebouché, B. (2022, April). Usability and acceptability of an artificial intelligence-based Chatbot to facilitate antiretroviral self-management in people living with HIV [Presentation]. In 31st annual Canadian Conference on HIV/AIDS Research (CAHR 2022). Unavailable
Ma, Y., Engler, K., Vincente, S., Achiche, S., Lemire, B., Rodrigez Cruz, A., Thériault, L., Soussou, S., Régazzoni, B., Tu, G., Nait Ei Haj, M., de Pokomandy, A., Cox, J., Zahedi Niaki, N., & Lebouché, B. (2022, April). Utilisabilité et acceptabilité d'un Chatbot basé sur l'intelligence artificielle pour faciliter l'autogestion des antirétroviraux chez les personnes vivant avec le VIH [Poster]. 11ème conférence internationale francophone de Alliance francophone des acteurs de santé contre le VIH et les infections virales chroniques ou émergentes (AFRAVIH 2022), Marseille, France. External link
